Gossec, L., Nash, P., Mease, P. J., Rampakakis, E., Coates, L. C., Helliwell, P. S., . . . Shiff, N. J. Guselkumab provides durable improvement across psoriatic arthritis disease domains: Post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study. BMJ Publishing Group.
Chicago Style (17th ed.) CitationGossec, Laure, et al. Guselkumab Provides Durable Improvement Across Psoriatic Arthritis Disease Domains: Post Hoc Analysis of a Phase 3, Randomised, Double-blind, Placebo-controlled Study. BMJ Publishing Group.
MLA (9th ed.) CitationGossec, Laure, et al. Guselkumab Provides Durable Improvement Across Psoriatic Arthritis Disease Domains: Post Hoc Analysis of a Phase 3, Randomised, Double-blind, Placebo-controlled Study. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.